tiprankstipranks
Tango Therapeutics (TNGX)
NASDAQ:TNGX
US Market
TNGX
Tango Therapeutics
RESEARCH TOOLSreports

Tango Therapeutics (TNGX) Income Statement

448 Followers

Tango Therapeutics Income Statement

Last quarter (Q4 2025), Tango Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Tango Therapeutics's net income was $-38.75M. See Tango Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 62.38M$ 42.07M$ 36.53M$ 24.86M$ 37.04M
Gross Profit
$ 60.10M$ 42.07M$ 36.53M$ 24.86M$ 37.04M
Operating Expenses
$ 171.39M$ 187.66M$ 150.70M$ 135.93M$ 95.23M
Depreciation and Amortization
$ 2.28M$ 2.50M$ 2.42M$ 1.61M$ 897.00K
EBITDA
$ -109.01M$ -143.10M$ -111.76M$ -109.46M$ -57.29M
Operating Income
$ -111.29M$ -145.59M$ -114.17M$ -111.07M$ -58.19M
Other Income/Expenses
$ 9.70M$ 15.50M$ 12.56M$ 2.95M$ 247.00K
Pretax Income
$ -101.59M$ -130.09M$ -101.61M$ -108.12M$ -57.94M
Net Income
$ -101.59M$ -130.30M$ -101.74M$ -108.18M$ -58.23M
Per Share Metrics
Basic EPS
$ -0.87$ -1.19$ -1.08$ -1.23$ -0.94
Diluted EPS
$ -0.87$ -1.19$ -1.08$ -1.23$ -0.94
Weighted Average Shares Outstanding
 116.17M 109.23M 94.57M 87.82M 62.11M
Weighted Average Shares Outstanding (Diluted)
 116.17M 109.23M 94.57M 87.82M 62.11M
Currency in USD

Tango Therapeutics Earnings and Revenue History